Search results
Results from the WOW.Com Content Network
Orthostatic hypotension, also known as postural hypotension, [2] is a medical condition wherein a person's blood pressure drops when they are standing up (orthostasis) or sitting down. Primary orthostatic hypotension is also often referred to as neurogenic orthostatic hypotension. [ 3 ]
Tamsulosin is primarily used for benign prostatic hyperplasia (BPH) and to help with the passage of kidney stones. [13] [14] Tamsulosin, however, appears to be effective only for stones over 4 mm and less than 10 mm in size. [8] Tamsulosin is also used as an add-on treatment for acute urinary retention. People may void more successfully after ...
Orthostatic hypotension; Nasal congestion; Dizziness; Lack of energy; Headache; Drowsiness [2] [10] Tamsulosin: Flomax A blocker that has slight selectivity for α 1 receptors. [2] Relaxation of prostatic smooth muscle. [2] Benign prostatic hyperplasia [2] [11] Orthostatic hypotension [2] Yohimbine: Yocon
Orthostatic syncope refers to syncope resulting from a postural decrease in blood pressure, termed orthostatic hypotension. [1]Orthostatic hypotension occurs when there is a persistent reduction in blood pressure of at least 20mmHg systolic or 10mmHg diastolic within three minutes of standing or being upright to 60 degrees on the head-up tilt table.
Etilefrine, sold under the brand name Effortil among others, is a sympathomimetic medication used as an antihypotensive agent to treat orthostatic hypotension. [1] It is usually used by mouth, but is also available as an injectable. [3] [4] Side effects of etilefrine include nausea, tremors, and palpitations, among others. [5]
The majority of symptoms that patients with PAF exhibit are associated with neurogenic orthostatic hypotension, or orthostatic hypotension brought on by severe sympathetic failure. Within three minutes of standing up straight, orthostatic hypotension is defined as a drop in systolic blood pressure of at least 20 mm Hg or a drop in diastolic ...
Midodrine is indicated for the treatment of symptomatic orthostatic hypotension. It can reduce dizziness and faints by about a third, but can be limited by troublesome goose bumps, skin itch, gastrointestinal discomfort, chills, elevated blood pressure while lying down, and urinary retention. [7]
Droxidopa was developed by Sumitomo Pharmaceuticals for the treatment of hypotension, including NOH, [7] and NOH associated with various disorders such as MSA, FAP, and PD, as well as IDH. The drug has been used in Japan and some surrounding Asian areas for these indications since 1989.